about
Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabul...
Read More
2.43
-0.12
(-4.71%)
49,564
XNAS Volume
XNAS 09 Apr, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Veru Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..